Effectiveness of Mesenchymal Stem Cell Therapy for COVID-19-Induced ARDS Patients: A Case Report

Kwangmin Kim, Keum Seok Bae, Hyun Soo Kim, Won-Yeon Lee

Open source

DOI
10.3390/medicina58121698
Published
2022-11-22
Container
Medicina
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/medicina58121698,
  title = {Effectiveness of Mesenchymal Stem Cell Therapy for COVID-19-Induced ARDS Patients: A Case Report},
  author = {Kwangmin Kim and Keum Seok Bae and Hyun Soo Kim and Won-Yeon Lee},
  year = {2022},
  journal = {Medicina},
  doi = {10.3390/medicina58121698},
  url = {https://doi.org/10.3390/medicina58121698}
}

RIS

TY  - JOUR
TI  - Effectiveness of Mesenchymal Stem Cell Therapy for COVID-19-Induced ARDS Patients: A Case Report
AU  - Kwangmin Kim
AU  - Keum Seok Bae
AU  - Hyun Soo Kim
AU  - Won-Yeon Lee
PY  - 2022
JO  - Medicina
DO  - 10.3390/medicina58121698
UR  - https://doi.org/10.3390/medicina58121698
ER  - 

APA

Kim, K., Bae, K. S., Kim, H. S., & Lee, W. (2022). Effectiveness of Mesenchymal Stem Cell Therapy for COVID-19-Induced ARDS Patients: A Case Report. Medicina. https://doi.org/10.3390/medicina58121698

Source records